Basilea Pharmaceutica AG (BPMUF)
Basilea Pharmaceutica Market Cap : 871.29M for Feb. 27, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| EvoNext Holdings SA | 8.438M |
| Kuros Biosciences Ltd. | 1.254B |
| Santhera Pharmaceuticals Holding AG | 274.35M |
| BeOne Medicines Ltd. | 35.08B |
| AC Immune SA | 294.76M |
Market Cap Related Metrics
| PE Ratio | 19.33 |
| PS Ratio | 3.463 |
| PEG Ratio | 0.0319 |
| Price to Free Cash Flow | 13.15 |
| Price | 71.00 |
| Earnings Yield | 5.17% |
| PEGY Ratio | 0.0319 |
| Operating PE Ratio | 15.63 |
| Normalized PE Ratio | 19.33 |